Pharmacy Times October 28, 2024
Pharmacists play a key role when it comes to medication substitution, especially for interchangeable biosimilars where allowed by state law.
More biosimilars continue to be developed, and as they come to market, they should help lower costs. Systemic barriers continue to limit access, and therefore, savings. Market manipulation by drug manufacturers, complexities caused by formulary placement by large pharmacy benefits managers (PBMs), administrative hurdles, and an array of variations in biosimilar products led to patient and physician confusion and lack of adoption. As a result, high-cost brand biologics continuing their market dominance.
The 2 previous articles in this series explored these challenges and their impact. The barriers they created have been obvious in the lack of update of lower cost...
Today's Sponsors
Today's Sponsor